Eterna Therapeutics
ERNA
ERNA
41 hedge funds and large institutions have $5.66M invested in Eterna Therapeutics in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
67% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 24
85% less capital invested
Capital invested by funds: $38.4M → $5.66M (-$32.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
41
Holding in Top 10
–
Calls
$96K
Puts
$2K
Top Buyers
| 1 | +$328K | |
| 2 | +$170K | |
| 3 | +$75K | |
| 4 |
Two Sigma Investments
New York
|
+$61.2K |
| 5 |
Goldman Sachs
New York
|
+$28.3K |
Top Sellers
| 1 | -$607K | |
| 2 | -$362K | |
| 3 | -$241K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$230K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$214K |